What if Swine Flu Meets Bird Flu?

(NEWSER) - With panic over the H1N1 flu virus on the wane, some Americans are pondering allowing themselves to become infected in hopes of building immunity against potentially more virulent strains, the New York Times reports. Doctors are split on the idea. "I think it's totally nuts," says a flu specialist. "We don't know enough about how this virus could react." More»

Watchdogs accuse WHO of colluding with drugmakers

(NEWSER) - Was the H1N1 pandemic exaggerated? European officials are putting heat on the WHO over its handling of the pandemic, alleging the organization caused unnecessary panic and wasted millions of dollars. Reports released by an EU watchdog and the British Medical Journal go even further: they accuse the WHO of being influenced by drugmakers who stood to profit from unnecessary influenza preparation, the Washington Post reports. More»

History, and this past spring, show novel strains 'crowd out' normal ones

(NEWSER) - A perfect storm of factors related to the swine flu pandemic have many experts predicting the usual seasonal flu viruses will be no-shows this season. First off, the rush for H1N1 vaccinations saw many patients being vaccinated for the seasonal varieties as well. And then there’s “crowding out,” a little-understand phenomenon that means novel flu strains essentially monopolize patients' lungs. More»

Tamiflu-resistant cluster crops up in NC; 3 of 4 patients dead

(NEWSER) - The swine flu outbreak is slacking off in some areas, but don't get complacent, officials say: Pandemics naturally fluctuate. "There can be multiple ups and downs over the season," says a CDC doctor. "We have many weeks ahead of us where disease is going to be circulating." Infections in people under 65 have dropped in the past month, but the holiday season is a recipe for transmission. More»

Older kids, like adults, get effective H1N1 inoculation from just 1 dose

(NEWSER) - Kids over age 9 can safely join adults in receiving just one shot of swine flu vaccine, the Washington Post reports. A test of 650 subjects showed 76% of children between 10 and 17 had a response to a vaccine produced by Sanofi Pasteur, and it was strong enough that protection from the virus could be assumed. Kids under 10 will still need two doses—only 25% to 36% of them exhibited a strong vaccine response. More»